We investigated whether each of the independent biomarkers associated with SSc (i.e., EMPs, CD34+CD45− EPCs, endothelin-1 and s-Fractalkine) could be associated with the clinical characteristics of patients with SSc. The gene discussed is EDN1; the disease is systemic sclerosis.